Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus
Authors:
- B. SchöttkerBSB. Schöttker
- H. MüllerHMH. Müller
- D. RothenbacherDRD. Rothenbacher
- H. BrennerHBH. Brenner
- 19 September 2012
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 56 (1) , 92-100
Abstract
Aims/hypothesis This study aimed to assess the cardiovascular risk of individuals with fasting plasma glucose (FPG)- and/or HbA1c-defined prediabetes (5.6–6.9 mmol/l and 39–47 mmol/mol [5.7–6.4%], respectively) or manifest diabetes mellitus and to evaluate whether FPG or HbA1c can improve risk prediction beyond that estimated by the Systematic Coronary Risk Evaluation (SCORE) chart in individuals without diabetes mellitus. Methods Cox regression was employed to estimate HRs for primary incident cardiovascular events (CVEs) in a cohort of 8,365 individuals aged 50–74 years. Furthermore, HbA1c and FPG were added individually to the variables of the SCORE and measures of model discrimination and reclassification were assessed. Results During 8 years of follow-up, 702 individuals had a primary CVE. After adjusting for conventional cardiovascular risk factors, HRs were attenuated close to one for the prediabetes groups (especially for women), whereas a 1.7- and a 1.9-fold increased risk persisted for men and women with diabetes, respectively. Extension of the SCORE variables by either FPG or HbA1c did not improve its predictive abilities in individuals without diabetes. There was a non-significant net reclassification improvement for men when HbA1c was added (2.2%, p = 0.16). Conclusions/interpretation The increased cardiovascular risk of individuals with FPG- or HbA1c-defined prediabetes can mainly be explained by other cardiovascular risk factors. Adding FPG or HbA1c did not significantly improve CVE risk prediction by the SCORE variables in individuals without diabetes mellitus.Keywords
This publication has 34 references indexed in Scilit:
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2011
- Are the Same Clinical Risk Factors Relevant for Incident Diabetes Defined by Treatment, Fasting Plasma Glucose, and HbA1c?Diabetes Care, 2011
- Methods for evaluating novel biomarkers - a new paradigmInternational Journal Of Clinical Practice, 2010
- Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. AdultsDiabetes Care, 2010
- A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk FactorsDiabetes Care, 2010
- Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular DiseaseDiabetes Care, 2010
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic ReviewPLOS Medicine, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up studyThe Lancet, 2008